GHK-Cu vs TB-500
Research Verdict
GHK-Cu is the stronger research reference for the stated comparison criteria. GHK-Cu has the stronger evidence when human evidence matters; TB-500 fragment 17-23 remains preclinical.
Quick Answers
Which is better, GHK-Cu or TB-500?
GHK-Cu is the stronger research reference for the stated comparison criteria. GHK-Cu has the stronger evidence when human evidence matters; TB-500 fragment 17-23 remains preclinical.
What is the key difference between GHK-Cu and TB-500?
GHK-Cu is a copper-binding tripeptide studied mainly for skin and matrix remodeling. TB-500 is a seven-amino-acid thymosin beta-4 fragment studied directly in an animal tendon model.
Evidence Comparison
GHK-Cu has small independent human studies for topical skin outcomes. Direct TB-500 fragment evidence is limited to preclinical work, including a positive 2026 rat tendon study. RegeneRx trials used full-length thymosin beta-4 and cannot be counted as TB-500 fragment trials.
Evidence Context Favoring GHK-Cu
Topical skin, collagen, or matrix-remodeling research where direct human evidence matters.
Evidence Context Favoring TB-500
Preclinical tendon-healing research centered on the 2026 fragment-specific animal result.
Side-by-Side Snapshot
| Evidence grade | GHK-Cu: Level B TB-500: Level C |
|---|---|
| Research status | GHK-Cu: Phase 2 TB-500: Preclinical |
| Primary category | GHK-Cu: Skin & Beauty TB-500: Healing & Recovery |
| Cited studies | GHK-Cu: 6 TB-500: 9 |